OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SIKA.NLB54

Sika AG

Specialty ChemicalsVerified

Sika AG's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and lack of going-concern language in source documents, preventing a formal liquidity assessment. The company's valuation snapshot does not provide sufficient data to evaluate liquidity risk or capital structure dynamics. Profitability and returns data are not available in the current valuation snapshot, making it impossible to compare Sika AG's performance against industry_config preferred metrics or cohort medians. Without access to key profitability indicators such as ROIC, EBITDA margins, or net profit margins, a detailed assessment of the company's financial performance cannot be made. Sika AG's revenue is not segmented by geographic region or product line in the available data, so it is not possible to assess revenue concentration or geographic exposure. The company's operations are likely diversified across multiple regions, but the extent of this diversification remains unclear without further disclosure. The company's growth trajectory is not quantifiable due to the absence of historical revenue data and forward-looking guidance in the input. Analysts have provided a range of price targets, with a mean of 178.06 CHF and a median of 176.00 CHF, but these estimates do not include specific revenue growth projections or directional guidance for the current or next fiscal year. Risk factors for Sika AG include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The risk assessment also notes that dilution risk is low, with no evidence of dilution potential in the basic shares outstanding. However, the absence of balance-sheet data and going-concern language in source documents limits the ability to fully evaluate the company's financial health. Recent events and disclosures for Sika AG are not detailed in the input data. Analysts have issued a total of 20 recommendations, with 5 strong-buy, 9 buy, and 6 hold ratings, indicating a generally positive outlook among analysts. However, no specific filings, transcripts, or recent events are provided to support or contextualize these recommendations.

30-day price · SIKA.NLB+0.03 (+0.4%)
Low$6.45High$6.98Close$6.98As of29 May, 00:00 UTC
Profile
CompanySika AG
TickerSIKA.NLB
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Sika AG's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and lack of going-concern language in source documents, preventing a formal liquidity assessment. The company's valuation snapshot does not provide sufficient data to evaluate liquidity risk or capital structure dynamics. Profitability and returns data are not available in the current valuation snapshot, making it impossible to compare Sika AG's performance against industry_config preferred metrics or cohort medians. Without access to key profitability indicators such as ROIC, EBITDA margins, or net profit margins, a detailed assessment of the company's financial performance cannot be made. Sika AG's revenue is not segmented by geographic region or product line in the available data, so it is not possible to assess revenue concentration or geographic exposure. The company's operations are likely diversified across multiple regions, but the extent of this diversification remains unclear without further disclosure. The company's growth trajectory is not quantifiable due to the absence of historical revenue data and forward-looking guidance in the input. Analysts have provided a range of price targets, with a mean of 178.06 CHF and a median of 176.00 CHF, but these estimates do not include specific revenue growth projections or directional guidance for the current or next fiscal year. Risk factors for Sika AG include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The risk assessment also notes that dilution risk is low, with no evidence of dilution potential in the basic shares outstanding. However, the absence of balance-sheet data and going-concern language in source documents limits the ability to fully evaluate the company's financial health. Recent events and disclosures for Sika AG are not detailed in the input data. Analysts have issued a total of 20 recommendations, with 5 strong-buy, 9 buy, and 6 hold ratings, indicating a generally positive outlook among analysts. However, no specific filings, transcripts, or recent events are provided to support or contextualize these recommendations.
Key takeaways
  • Sika AG operates in the specialty chemicals industry, focusing on construction chemicals, sealants, and adhesives.
  • The company's liquidity and capital structure cannot be assessed due to missing balance-sheet data.
  • Analysts have issued a generally positive outlook, with a mean price target of 178.06 CHF.
  • Revenue concentration and geographic exposure are not disclosed in the available data.
  • Dilution risk is currently low, but liquidity risk remains unassessable.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCHF
Revenue$2.65B
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$9.25B$1.39B$1.05B$889.8M
FY-3$10.49B$1.58B$1.16B$835.2M
FY-2$11.24B$1.55B$1.06B$775.7M
FY-1$11.76B$1.71B$1.25B$1.18B
FY0$11.20B$1.49B$1.04B$922.8M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$10.71B$4.39B$1.18B
FY-3$11.32B$4.97B$1.87B
FY-2$15.05B$5.92B$643.9M
FY-1$15.98B$7.03B$707.5M
FY0$15.15B$6.66B$801.8M
PeriodOCFCapExFCFSBC
FY-4$1.06B-$170.8M$889.8M
FY-3$1.10B-$266.0M$835.2M
FY-2$1.71B-$279.9M$775.7M
FY-1$1.74B-$359.0M$1.18B
FY0$1.71B-$375.4M$922.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$2.65B
FQ-6
FQ-5$3.08B$472.5M$345.3M
FQ-4
FQ-3$2.68B
FQ-2
FQ-1$2.90B$439.8M$316.1M
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSIKA.NLBActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Observations
IR observations
Mean price target178.06 CHF
Median price target176.00 CHF
High price target226.00 CHF
Low price target125.00 CHF
Mean recommendation2.30 (1=strong buy, 5=strong sell)
Strong-buy count5.00
Buy count9.00
Hold count6.00
Sell count3.00
Strong-sell count0.00
Mean EPS estimate7.21 CHF
Last actual EPS7.76 CHF
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 07:16 UTC#545859f8
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 10:47 UTCJob: f7a33d1a